<DOC>
	<DOCNO>NCT02337335</DOCNO>
	<brief_summary>Assesment predictive model anemia management : Dosage erythropoietin ( EPO ) Iron adminsitration hemodialysis patient .</brief_summary>
	<brief_title>Assesment Predictive Model Dosage EPO Hemodialysis Patients</brief_title>
	<detailed_description>Anemia patient hemodialysis ( HD ) common although usually respond well treatment Erythropoiesis Stimulating Agents ( ESAs ) , dosage , base different clinical protocol , often ignore high variability inter- intra -individual patient response . The result lead swing objective different dosage range associate multiple risk side effect . There artificial intelligence-based optimization method predict treatment ESAs maintain patient hemoglobin target range . So far model validate long half-life EPO ( darbepoetin ) promising result . HYPOTHESIS : Maintaining patient Hb level ESAs range use short half-life , avoid one hand , need transfusion , secondly , level exceed upper range ( overshoot ) , prevent onset increase cardiovascular risk event . RELEVANCE : The result allow u validate model short half-life ESAs optimize management anemia improve comorbidity associate overdosage . SUMMARY : Prospective observational study pair data . Data obtain data base Euclid . Data collect clinical team accord standard clinical practice . Informed time admission clinic consent obtain . All patient data include november 15th 2014 complete study period 30 april 2015 . The result compare prior patient 's inclusion study process . To detect difference 10 % percentage patient hemoglobin target range intervention ( 70 % 80 % ) need minimum sample size 268 patient assume alpha error 0.05 , beta error 0.2 correlation observation 0.1 .</detailed_description>
	<criteria>&gt; 18 Years &gt; 3 Months HD / OLHDF Treated ESAs ( epoBeta ) &gt; 3 Months Chronic inflammatory disease Liver Cirrhosis Active Neoplasms Immunosuppression antiinflammatory medication Patients require treatment ESAs</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2015</verification_date>
	<keyword>Hemodialyisis</keyword>
	<keyword>Predictive Model</keyword>
	<keyword>ESAs</keyword>
	<keyword>patient</keyword>
</DOC>